Welcome to LookChem.com Sign In|Join Free

CAS

  • or

260270-95-9

Post Buying Request

260270-95-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

260270-95-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 260270-95-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,0,2,7 and 0 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 260270-95:
(8*2)+(7*6)+(6*0)+(5*2)+(4*7)+(3*0)+(2*9)+(1*5)=119
119 % 10 = 9
So 260270-95-9 is a valid CAS Registry Number.

260270-95-9Relevant articles and documents

Enantioselective and Diastereodivergent Access to α-Substituted α-Amino Acids via Dual Iridium and Copper Catalysis

Zhang, Jiacheng,Huo, Xiaohong,Li, Bowen,Chen, Zhouli,Zou, Yashi,Sun, Zhenliang,Zhang, Wanbin

, p. 1130 - 1139 (2019)

The work reported within this paper describes an example of the application of bimetallic catalysts system in allylic substitution reactions. The development of new nucleophiles and the control of enantio- and diastereoselectivity are the main research topics in this area. An improvement in the reactivity and diastereoselectivity has been realized for the dual Ir/Cu catalyzed allylic alkylation of inactive prochiral nucleophiles, under mild reaction conditions. Furthermore, the choice of the metallacyclic iridium complex and chiral Cu-Phox complex combination allows for access to all four stereoisomers from the same starting materials with excellent enantioselectivity and diastereoselectivity (up to >99% ee and >20:1 dr). Significantly, this method provides a stereodivergent access to 2-amino-3-methylpent-4-acid ester, an important fragment for the synthesis of Halipeptin A. (Figure presented.).

Design of selective and soluble inhibitors of tumor necrosis factor-α converting enzyme (TACE)

Rabinowitz,Andrews,Becherer,Bickett,Bubacz,Conway,Cowan,Gaul,Glennon,Lambert,Leesnitzer,McDougald,Moss,Musso,Rizzolio

, p. 4252 - 4267 (2007/10/03)

A program to improve upon the in vitro, in vivo, and physicochemical properties of N-hydroxyformamide TACE inhibitor GW 3333 (1) is described. Using the primary structure of pro-TNF-α, along with a homology model of the catalytic domain of TACE based on t

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 260270-95-9